Trivant Custom Portfolio Group, LLC Embecta Corp. Transaction History
Trivant Custom Portfolio Group, LLC
- $173 Billion
- Q3 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 1 shares of EMBC stock, worth $14. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$14
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EMBC
# of Institutions
404Shares Held
51.4MCall Options Held
162KPut Options Held
61K-
Black Rock Inc. New York, NY9.19MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$98.8 Million0.0% of portfolio
-
River Road Asset Management, LLC3.48MShares$49.1 Million0.69% of portfolio
-
American Century Companies Inc Kansas City, MO3.02MShares$42.6 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.73MShares$38.6 Million0.72% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $817M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...